Ad is loading...
ACXP
Price
$1.30
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
110 days until earnings call
RCUS
Price
$14.70
Change
+$0.42 (+2.94%)
Updated
Nov 22 closing price
88 days until earnings call
Ad is loading...

ACXP vs RCUS

Header iconACXP vs RCUS Comparison
Open Charts ACXP vs RCUSBanner chart's image
Acurx Pharmaceuticals
Price$1.30
Change-$0.00 (-0.00%)
Volume$320.09K
CapitalizationN/A
Arcus Biosciences
Price$14.70
Change+$0.42 (+2.94%)
Volume$534.48K
CapitalizationN/A
ACXP vs RCUS Comparison Chart
Loading...
ACXP
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RCUS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
ACXP vs. RCUS commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACXP is a Hold and RCUS is a Hold.

COMPARISON
Comparison
Nov 23, 2024
Stock price -- (ACXP: $1.35 vs. RCUS: $14.70)
Brand notoriety: ACXP and RCUS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACXP: 253% vs. RCUS: 70%
Market capitalization -- ACXP: $22.8M vs. RCUS: $1.35B
ACXP [@Biotechnology] is valued at $22.8M. RCUS’s [@Biotechnology] market capitalization is $1.35B. The market cap for tickers in the [@Biotechnology] industry ranges from $450.11B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACXP’s FA Score shows that 0 FA rating(s) are green whileRCUS’s FA Score has 0 green FA rating(s).

  • ACXP’s FA Score: 0 green, 5 red.
  • RCUS’s FA Score: 0 green, 5 red.
According to our system of comparison, RCUS is a better buy in the long-term than ACXP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACXP’s TA Score shows that 4 TA indicator(s) are bullish while RCUS’s TA Score has 4 bullish TA indicator(s).

  • ACXP’s TA Score: 4 bullish, 6 bearish.
  • RCUS’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, RCUS is a better buy in the short-term than ACXP.

Price Growth

ACXP (@Biotechnology) experienced а -21.51% price change this week, while RCUS (@Biotechnology) price change was -6.37% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.38%. For the same industry, the average monthly price growth was -4.87%, and the average quarterly price growth was +4.35%.

Reported Earning Dates

ACXP is expected to report earnings on Mar 13, 2025.

RCUS is expected to report earnings on Feb 19, 2025.

Industries' Descriptions

@Biotechnology (+2.38% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RCUS($1.35B) has a higher market cap than ACXP($22.8M). RCUS YTD gains are higher at: -23.037 vs. ACXP (-64.752). ACXP has higher annual earnings (EBITDA): -16.44M vs. RCUS (-257M). RCUS has more cash in the bank: 1.09B vs. ACXP (5.76M). RCUS has higher revenues than ACXP: RCUS (263M) vs ACXP (0).
ACXPRCUSACXP / RCUS
Capitalization22.8M1.35B2%
EBITDA-16.44M-257M6%
Gain YTD-64.752-23.037281%
P/E RatioN/AN/A-
Revenue0263M-
Total Cash5.76M1.09B1%
Total DebtN/A58M-
FUNDAMENTALS RATINGS
RCUS: Fundamental Ratings
RCUS
OUTLOOK RATING
1..100
73
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
PROFIT vs RISK RATING
1..100
77
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACXPRCUS
RSI
ODDS (%)
Bullish Trend 1 day ago
89%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
85%
MACD
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 1 day ago
79%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
74%
Advances
ODDS (%)
Bullish Trend 25 days ago
79%
Bullish Trend 3 days ago
82%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 5 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
ACXP
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RCUS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TCRX4.260.32
+8.12%
TScan Therapeutics
VIR7.120.17
+2.45%
Vir Biotechnology
CRC59.590.01
+0.02%
California Resources Corp
EME504.92-22.03
-4.18%
EMCOR Group
AEON0.53-0.03
-5.17%
AEON Biopharma

ACXP and

Correlation & Price change

A.I.dvisor tells us that ACXP and RCUS have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ACXP and RCUS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACXP
1D Price
Change %
ACXP100%
+3.85%
RCUS - ACXP
30%
Poorly correlated
+2.94%
OTLK - ACXP
29%
Poorly correlated
-1.95%
RLAY - ACXP
28%
Poorly correlated
+2.37%
LCTX - ACXP
27%
Poorly correlated
-16.02%
INZY - ACXP
26%
Poorly correlated
+4.46%
More

RCUS and

Correlation & Price change

A.I.dvisor indicates that over the last year, RCUS has been loosely correlated with ACLX. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if RCUS jumps, then ACLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCUS
1D Price
Change %
RCUS100%
+2.94%
ACLX - RCUS
47%
Loosely correlated
+3.69%
DNLI - RCUS
46%
Loosely correlated
+1.94%
PRME - RCUS
46%
Loosely correlated
+7.74%
ALEC - RCUS
45%
Loosely correlated
+4.79%
ABCL - RCUS
45%
Loosely correlated
+1.47%
More